Clinical trial Recruiting at 1 site Interventional Ages 11 to 18

Program to improve sleep and reduce suicidal behavior in adolescents

Official title: Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior

Run by Nationwide Children's Hospital · NCT05390918 · Data updated 2026-11-12

This study is testing a new program to help teenagers who have trouble sleeping and are feeling suicidal, to see if it can improve their sleep and reduce their suicidal thoughts.

Quick facts

Study typeInterventional
Ages11 Years to 18 Years
SexAll
Enrollment235 (estimated)
SponsorNationwide Children's Hospital
Academic / other
Locations1 site (Columbus, Ohio)
StatusRecruiting
StartedOctober 20, 2022
Main results expectedFebruary 2027
Study endsFebruary 2027
Registry record updatedFebruary 5, 2026
Trial IDNCT05390918 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adolescents aged 11 to 18 who have experienced recent suicidal ideation and sleep problems.

Probably not a fit

Patients who have attempted suicide in the past three months or have certain psychiatric diagnoses will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study tests the TAILOR program, which aims to improve sleep and reduce suicidal ideation in adolescents facing sleep difficulties and recent suicidal thoughts. The intervention combines Cognitive Behavioral Therapy, Motivational Interviewing, and remote support to address both sleep issues and suicidal risk. Participants will be compared to a control group receiving Enhanced Usual Care to evaluate the effectiveness of TAILOR over a period of four months.

Why it matters

Potential benefit: If successful, this program could significantly reduce sleep problems and suicidal thoughts in adolescents, improving their overall mental health.

How similar studies have gone: Other studies have shown promise in using behavioral interventions for sleep and suicide prevention, suggesting that this approach may be effective.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion:

* Nationwide Children's Hospital patients
* Between the ages of 11 years, 0 months, and 18 years, 11 months, inclusive at time of consent
* Endorse both recent (past 90 days) suicidal ideation and sleep problems (past 30 days)
* Resides with primary caregiver who has legal authority to consent to research participation

Exclusion:

* Suicide attempt in the past 3 months
* Diagnosis of Bipolar Disorder or Psychosis
* Having a change to an antipsychotic and/or mood stabilizer medication regimen within the last 2 months
* Snoring at least 3 nights per week that can be heard a room or two away, even without a cold or flu or during allergy season
* Gasping for air while sleeping, diagnosis of Obstructive Sleep Apnea, or turning blue within the past year
* Body Mass Index \> 40
* Daytime symptoms of Restless Leg Syndrome
* Diagnosis of Narcolepsy
* Diagnosis of Seizures or Epilepsy, or prescribed anticonvulsant medication, within the past 4 years
* Significant substance use in the past month
* Currently receiving sleep disorder services from a sleep clinic
* Inability to speak/read English adequately to understand and complete study consent and procedures
* No access to a telephone or internet-connecting device
* Sibling already in the study

Where it's running

  • Nationwide Children's Hospital
    Columbus, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.